New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
12:18 EDTT, PRAN, NDZ, TEVA, MNTA, MYL, MUOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday in the last trading day of the first quarter of the year. The disappointing Chicago purchasing managers' report was offset by dovish comments from Fed Chief Yellen, who said the the central bank’s "extraordinary" aid will last for "some time.” ECONOMIC EVENTS: In the U.S., the Chicago PMI business barometer index came in at 55.9, versus the consensus forecast for a 59.0 reading. In Europe, the annual inflation rate across the 18-country eurozone fell for the third consecutive month, slipping to 0.5% in March, compared to analysts' consensus forecast for a milder drop to 0.6%. COMPANY NEWS: Shares of AT&T (T) advanced early in the session after the company's board of directors authorized the repurchase of up to 300M shares, or about 6% of its common shares outstanding. The company also noted it has 125M shares left under its buyback authorization that was issued in March of last year, but the stock had given up much of its early advance to be up fractionally near noon. MAJOR MOVERS: Among the notable gainers was Canada's Nordion (NDZ), which jumped 11% after the company agreed to be acquired by Sterigenics for $11.75 per share in cash shortly after Canada's government lifted its 25% limit on foreign investment in the company. Also higher following analyst commentary was Micron (MU), which rose nearly 8% amid notes in its defense from Stifel and Pacific Crest, as well as broad-based strength in technology stocks that have recently pulled back. Among the noteworthy losers were Momenta Pharmaceuticals (MNTA), which dropped 15%, and Mylan (MYL), which slipped over 1%, after the Supreme Court agreed to hear an appeal by Teva (TEVA) of a court ruling that would enable generic versions of its multiple sclerosis drug, Copaxone, to be sold in May. Also lower were shares of Prana Biotechnology (PRAN), which plunged over 70% after its clinical study of a drug being tested as a treatment of Alzheimer's Disease did not hit its primary endpoint. INDEXES: Near midday, the Dow was up 118.43, or 0.73%, to 16,441.49, the Nasdaq was up 52.48, or 1.26%, to 4,208.23, and the S&P 500 was up 14.56, or 0.78%, to 1,872.18.
News For T;PRAN;NDZ;TEVA;MNTA;MYL;MU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 20, 2014
08:04 EDTMYLGerman fund pressured to sell Mylan stake over drug used in executions, FT says
Subscribe for More Information
07:20 EDTMYLInternational Continence Society to hold annual meeting
ICS Annual Meeting 2014 is being held in Rio de Janeiro, Brazil on October 20-24.
07:15 EDTTAT&T weekly volatility elevated into Q3 and outlook
Subscribe for More Information
06:53 EDTMUMicron upgraded to Outperform from Sector Perform at Pacific Crest
Subscribe for More Information
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information
05:58 EDTMUMicron upgraded to Outperform from Sector Perform at Pacific Crest
October 17, 2014
11:51 EDTMUStocks with call strike movement; MU DAL
Subscribe for More Information
09:16 EDTMUMicron management to meet with MKM Partners
Meetings to be held in New York on October 23 and in the Mid-Atlantic area on October 24 hosted by MKM Partners.
07:31 EDTMUSamsung first to market with new multilayer NAND technology, Nikkei says
Subscribe for More Information
October 16, 2014
17:48 EDTMUMicron lower by over 1% to $28 after SanDisk Q3 results and guidance
14:47 EDTMUEarnings Preview: Pacific Crest, RBC positive on SanDisk ahead of report
Subscribe for More Information
08:29 EDTTAT&T sees 359K customers seek refunds for 'cramming' charges, Time reports
Subscribe for More Information
October 15, 2014
10:11 EDTTFrontier granted PURA approval for AT&T wireless ops. in Connecticut
Subscribe for More Information
10:02 EDTMUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:19 EDTMUMicron upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research
October 13, 2014
11:47 EDTPRANPrana founder claims breakthrough Alzheimer's approach, FierceBiotech says
The scientific founder of Prana Biotechnology, Massachusetts General Hospital investigator Rudy Tanzi, is asserting that he and his fellow researchers have come upon a new approach to growing brain cells in the lab that promises to "revolutionize" Alzheimer's research, reported FierceBiotech. Tanzi is the co-founding scientist and Chief Scientific Adviser at Prana. Reference Link
06:03 EDTMUStocks with implied volatility above IV index mean; HTZ MU
Subscribe for More Information
October 12, 2014
17:58 EDTMUMicron shares look more attractive, Barron's says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use